Enog, Hannan .
HRN: 26-78-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
METRONIDAZOLE 500MG (TAB)
03/04/2025
03/05/2025
IVT
500mg
Q8
S/p Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes